Negative allosteric modulation of cannabinoid CB <sub>1</sub> receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception
Vishakh Iyer(Indiana University Bloomington), Andrea G. Hohmann(Northeastern University)
Cited by 2
Related Papers
Slowly Signaling G Protein–Biased CB2 Cannabinoid Receptor Agonist LY2828360 Suppresses Neuropathic Pain with Sustained Efficacy and Attenuates Morphine Tolerance and Dependence
|Molecular Pharmacology|2017|87
Cannabinoid CB2 Agonist AM1710 Differentially Suppresses Distinct Pathological Pain States and Attenuates Morphine Tolerance and Withdrawal
|Molecular Pharmacology|2018|68
Negative allosteric modulation of CB1 cannabinoid receptor signaling suppresses opioid-mediated tolerance and withdrawal without blocking opioid antinociception
|Neuropharmacology|2024|8
Mice lacking the endocannabinoid-synthesizing enzyme NAPE-PLD exhibit sex-dependent dysregulations in responsiveness to oxycodone and a natural reward
|bioRxiv (Cold Spring Harbor Laboratory)|2025|0